Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells

Madhavi Gangapuram1, Riccardo Jean1, Elizabeth Mazzio1

  • 1College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, U.S.A.

Anticancer Research
|November 1, 2016
PubMed

Insights

New tetrahydroisoquinoline (THIQ) compounds show promise as triple-negative breast cancer (TNBC) therapeutics. These THIQs halt TNBC cell proliferation by disrupting microtubule networks, independent of hormone receptors.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Cell Biology

Background:

  • Triple-negative breast cancer (TNBC) disproportionately affects African-Americans and lacks targeted therapies.
  • Current TNBC treatments include cytotoxic agents, but novel therapeutic strategies are needed.
  • Tetrahydroisoquinolines (THIQs) are a class of compounds with potential pharmacological activity.

Purpose of the Study:

  • To synthesize novel substituted tetrahydroisoquinoline (THIQ) moieties.
  • To evaluate the in vitro efficacy of synthesized THIQs against triple-negative breast cancer (TNBC) cells.
  • To elucidate the mechanism of action of promising THIQ compounds in TNBC.

Main Methods:

  • Synthesis of THIQs via N-amination of substituted isoquinolines, followed by ylide formation and reduction.
  • In vitro evaluation using differential scatter plots to assess ER modulation in MCF-7 and MDA-MB-231 cells.
  • Assays to determine antiproliferative effects, cell cycle arrest (G2 phase), DNA synthesis inhibition, and microtubule dynamics.

Main Results:

  • Successful synthesis of substituted THIQs in moderate to good yields.
  • Two lead THIQ compounds (GM-4-53 and GM-3-121) exhibited potent cytostatic effects on TNBC cells (MDA-MB-231) with IC50 < 2.5 μM.
  • These compounds induced mitotic arrest, inhibited DNA replication, disrupted microtubule polymerization, and caused multinucleation, acting independently of the estrogen receptor (ER).

Conclusions:

  • Specific THIQs possess significant antiproliferative activity against TNBC cells.
  • The mechanism involves direct interference with microtubule dynamics, leading to cell cycle arrest at the G2 phase.
  • THIQs represent a potential new class of ER-independent therapeutics for TNBC, warranting further investigation for safety and efficacy, including combination therapy with taxanes.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.8K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
6.4K
Microtubule Formation01:23

Microtubule Formation

Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation...
8.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K